Dongxing Securities Co., Ltd.'s verification opinion on the use of idle funds raised by Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. to temporarily supplement working capital

SZSI · Apr 26

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.